Melanocyte-stimulating Hormone

Most blood panels never measure alpha-MSH. Current send-out tests use a carefully handled frozen plasma sample from a blood draw, and major lab directories describe the result as lab-specific or research-use rather than a settled diagnostic test. That puts it in the research tier.

The first mistake is treating every MSH paper as the same test. MSH is a small family: alpha, beta, and gamma forms. Most current send-out tests measure alpha-MSH. Several older human papers measured beta-MSH. They are related POMC fragments, but a beta-MSH result is not the same analyte as plasma alpha-MSH.

What Alpha-MSH Actually Is

Alpha-MSH is one member of the melanocyte-stimulating hormone family. ACTH and beta-MSH are cut from the same POMC parent protein. Alpha-MSH shares its first 13 building blocks with ACTH, which makes the two easy to mix up. The blood test does not measure ACTH, and older beta-MSH findings need to be read as related evidence, not the same measurement.

In people, alpha-MSH is not mainly a classic pituitary-output hormone. The adult human intermediate lobe, the pituitary region that makes much of the MSH in many animals, is rudimentary. Human skin, immune cells, and brain tissue can make alpha-MSH-like fragments. In untreated Addison's disease, pituitary POMC output may still add to the signal because cortisol is low.

Skin Color Is Only Part of the Story

Alpha-MSH can switch on the pigment cells that darken skin and hair. That is why people born unable to make POMC often have severe early-childhood obesity, adrenal insufficiency, and red hair or pale skin, though only about half show the red-hair and fair-skin pattern.

But a plasma alpha-MSH value is a poor guide to visible skin color. Older studies measured beta-MSH, a related POMC fragment. Beta-MSH was very high in chronic kidney failure but did not match the degree of skin darkening. In women with contraceptive-associated chloasma, beta-MSH was no higher than in controls. Blood MSH and skin pigment do not move in lockstep.

Appetite and Weight

Alpha-MSH acts on a brain switch called MC4R that signals you have eaten enough. The strongest human evidence here comes from genetics, not from routine plasma alpha-MSH testing. People with complete POMC loss develop severe early-childhood obesity, adrenal insufficiency, and often red hair or pale skin. Rare beta-MSH variants can also raise obesity risk by weakening MC4R signaling.

Blood data are thinner. One pediatric study measured serum alpha-MSH, not plasma, and found high levels in children with reduced MC4R function. After successful weight loss in obese children, serum alpha-MSH rose rather than fell. A separate study in obese men found higher plasma alpha-MSH tracked worse insulin handling. Those findings are real, but they do not make alpha-MSH a stand-alone weight-loss marker.

Adrenal Failure and Skin Darkening

When the adrenal glands fail in primary adrenal insufficiency, cortisol drops. Cortisol normally restrains POMC output. A small plasma alpha-MSH study found untreated Addison's disease had about twice the alpha-MSH level of healthy adults. Older beta-MSH work found much larger rises, and beta-MSH fell with glucocorticoid treatment. That is related-peptide evidence, not proof that alpha-MSH is an adrenal diagnostic test.

Ischemic Stroke Outcomes

In a study of 111 people with ischemic stroke, those with higher alpha-MSH early on were more likely to be doing well months later, and that link held even after accounting for how severe the stroke was. In the most severe strokes, alpha-MSH dropped early. A separate small study found plasma alpha-MSH fell in people with acute brain injury and climbed back in most of those who recovered. These are prognostic signals, not treatments.

Why the Same Number Can Mean Opposite Things

Higher early alpha-MSH looked favorable after stroke. In obese men, higher alpha-MSH tracked worse insulin handling. Those facts only clash if you treat MSH as a simple good-number or bad-number marker. It is a readout of a broad signaling system. The meaning depends on why you measured it.

Which Way It Moves in Different Conditions

Source: Donahoo et al. 2008 and Abe et al. 1969 for adrenal findings; Zierath et al. 2011 for ischemic stroke; Roth et al. 2009 for childhood obesity.

The direction that matters depends on why you are looking. A high value paired with fatigue and skin changes points one way. A high value in a metabolic workup points another. The number earns its meaning only alongside the rest of the picture.

Why One Reading Tells You Little

Alpha-MSH drifts with things that have nothing to do with a new disease. Men averaged about a third higher than women in one adult study. One small seasonal study found higher levels in summer among very fair-skinned adults, while another study did not find a clear seasonal swing. Kidney disease and dialysis change alpha-MSH, though studies disagree on the direction: one hemodialysis study found it elevated, while a more recent study found it lower in chronic kidney disease.

Each lab may report its own range, but there is no accepted clinical cutoff that tells you what to do. The signal worth having, if any, is change over time in the same person, run by the same lab, with the same sample handling. A single value in isolation is the least useful way to use this marker.

When Results Can Be Misleading

• Kidney disease and dialysis: plasma alpha-MSH was high in one chronic hemodialysis study, especially when bacterial toxin was detectable in blood, but a more recent study found lower alpha-MSH in chronic kidney disease, so the direction in renal disease is not settled. Older beta-MSH studies found that kidney status strongly affected beta-MSH. An MSH-family result can reflect kidney or dialysis context rather than a primary melanocortin problem.
• Sex and season: men averaged higher than women in one adult plasma study. Very fair-skinned adults showed a summer-winter swing in one study, but this was not seen in another European study. Time of day matters less than it does for cortisol.
• Medicines and prep: some lab directories advise stopping steroid, ACTH, or blood-pressure medicines if possible before collection. Older beta-MSH work found dexamethasone lowered beta-MSH and metyrapone raised it. These drugs can shift POMC signaling without proving a melanocortin disease.
• Sample handling: alpha-MSH is fragile in blood. Many labs require EDTA plasma separated quickly and frozen; some require Trasylol. Serum, plasma, room-temperature samples, and different lab methods should not be compared as if they were interchangeable.